Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Notice to stakeholders: Release of guidance document: Information and submission requirements for biosimilar biologic drugs for the addition of an indication where there is no/minimal data required to accompany the submission - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 250067
Later capture
Notice to stakeholders: Release of guidance document: Information and submission requirements for biosimilar biologic drugs for the addition of an indication where there is no/minimal data required to accompany the submission - Canada.ca
Jan 2, 2026
hc-20260101
ID 428830
updated1 sections changed
1 sections changed0 added0 removed+0 / -1 linesChange ratio: 2%
--- +++ @@ -25,5 +25,4 @@ Address Locator: 0601B marwa.abusoufah@hc-sc.gc.ca Page details-Date modified: 2022-08-04